Inke welcomed Oscar Pamos as Senior Business Development Manager for ASPAC and MENA.

At Inke S.A., we are dedicated to the development and manufacture of high-quality Active Pharmaceutical Ingredients (APIs), specializing in complex synthesis processes, micronisation technologies, and high-potency APIs (HPAPIs) for respiratory, CNS and ophthalmic therapies. With over 25 years of expertise in micronisation and a proven track record in complex API development, Inke is recognized as a trusted partner in the global pharmaceutical industry. Based in Barcelona, Spain, we supply APIs to markets across Europe, the US, Japan, and beyond. Our commitment to quality and regulatory excellence is reflected in successful inspections by major health authorities, including the US-FDA, with the most recent inspection in April 2019. Our portfolio reflects a deep commitment to innovation, patent leadership, and scientific excellence. We develop, patent, and implement proprietary synthesis routes that meet stringent regulatory standards and deliver tailor-made solutions for our partners worldwide. In addition to our long-standing expertise in micronisation and inhalation therapies, Inke has broadened its capabilities to include HPAPI manufacturing and ophthalmic APIs, reinforcing our position as a reliable supplier of complex, high-value pharmaceutical ingredients. Through continuous R&D investment, advanced laboratory facilities, and a diversified portfolio covering respiratory, CNS, specialty, and ophthalmic areas, Inke continues to push the boundaries of pharmaceutical innovation — developing reliable, high-quality solutions that improve patient outcomes. To learn more about our expertise in inhalation, HPAPIs, and ophthalmic APIs, please contact us at contact-inke@inke.es